1976
DOI: 10.1055/s-0028-1104235
|View full text |Cite
|
Sign up to set email alerts
|

Trizyklische Antidepressiva - Klinik und Therapie der Intoxikation

Abstract: Bei den trizyklischen Antidepressiva oder Thymo(ana)leptika handelt es sich um Pharmaka, die eine spezielle antidepressive sowie psychomotorisch aktivierende Wirkung aufweisen und bei denen der neuroleptische Effekt in den Hintergrund tritt. Die Thymoleptika, die für unsere Betrachtung von Interesse sind, gehören neben den Monoaminoxidase-Hemmern zur Gruppe der Antidepressiva. Chemisch können diese Verbindungen vom Chiorpromazin abgeleitet werden (Abbildung 1), das seit 1952 in der psychiatrischen Therapie ver… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
3
0

Year Published

1977
1977
1996
1996

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…When used in therapeutic doses electrocardiographic changes and cardiovascular effects may occur in predisposed patients suffering from cardiac disease (Moir et al 1972;Jefferson 1975;Brorson & Wennerblom 1978), whereas acute overdose with TCA may result in severe disturbances such as sinus tachycardia, conduction defects, supraventricular tachycardia, ST and T wave abnormalities, ventricular arrhytmias, profound bradycardia, hypotension and depression of myocardial contractility (Barnes et al. 1968;Anderson et al 1971;Burrows et al 1976;Rasenack & Gattenlohner 1976;Thorstrand 1976). The electrocardiographic and cardiovascular complications caused by the TCA's are often ascribed the combined effect of the many different pharmacological actions of these drugs such as inhibition of t h e neuronal uptake mechanism for noradrenaline, anticholinergic action, a-adrenolytic action a n d membrane effects (Barth & Muscholl 1974& 1976Elonen 1974; Elonen et al 1974).…”
mentioning
confidence: 99%
“…When used in therapeutic doses electrocardiographic changes and cardiovascular effects may occur in predisposed patients suffering from cardiac disease (Moir et al 1972;Jefferson 1975;Brorson & Wennerblom 1978), whereas acute overdose with TCA may result in severe disturbances such as sinus tachycardia, conduction defects, supraventricular tachycardia, ST and T wave abnormalities, ventricular arrhytmias, profound bradycardia, hypotension and depression of myocardial contractility (Barnes et al. 1968;Anderson et al 1971;Burrows et al 1976;Rasenack & Gattenlohner 1976;Thorstrand 1976). The electrocardiographic and cardiovascular complications caused by the TCA's are often ascribed the combined effect of the many different pharmacological actions of these drugs such as inhibition of t h e neuronal uptake mechanism for noradrenaline, anticholinergic action, a-adrenolytic action a n d membrane effects (Barth & Muscholl 1974& 1976Elonen 1974; Elonen et al 1974).…”
mentioning
confidence: 99%
“…Firstly, it is known that TCA inhibit the reuptake of norepinephrine at adrenergic receptors (Harper & Hughes 1977), leading to an increased level of circulating catecholamines. Secondly, TCA intensify the norepinephrine responses (Rasenack & Gattenlohner 1976) with development of increased arterial blood pressure and cardiac contractility. Peripheral vasodilatation due to an alfa-receptor blocking effect is well documented (Callingham 1967).…”
mentioning
confidence: 99%
“…Peripheral vasodilatation due to an alfa-receptor blocking effect is well documented (Callingham 1967). Blockade of betareceptors leading to decreased myocardial contractility has been suggested by Rasenack & Gattenlohner (1976).…”
mentioning
confidence: 99%